Endo Usa, Inc.: Buprenorphine Hydrochloride, Injection, 0.3mg/ml, 5x1 Ml Single Dose Vials
- Recalling firm
- ENDO USA, Inc.
- Product
- Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
- Reason
- Presence of particulate matter: identified as Buprenorphine free base
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-03-13
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- USA Nationwide
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/9931296f-21b8-4aed-adbe-eeba3e2b97d7